Abstract
Radio Guided Surgery (RGS) is a nuclear medicine technique allowing the surgeon to identify tumor residuals in real time with a millimetric resolution, thanks to a radiopharmaceutical as tracer and a probe as detector. The use of β− emitters, instead of γ or β+, has been recently proposed with the aim to increase the technique sensitivity and reducing both the administered activity to the patient and the medical exposure. In this paper, the possibility to use the commercial CMOS Image Sensor MT9V115, originally designed for visible light imaging, as β− radiation detector RGS is discussed. Being crucial characteristics in a surgical environment, in particular its stability against time, operating temperature, integration time and gain has been studied on laboratory measurements. Moreover, a full Monte Carlo simulation of the detector has been developed. Its validation against experimental data allowed us to obtain efficiency curves for both β and γ particles, and also to evaluate the effect of the covering heavy resin protective layer that is present in the “off the shelf” detector. This study suggests that a dedicated CMOS Image Sensor (i.e. one produced without the covering protective layer) represents the ideal candidate detector for RGS, able to massively increase the amount of application cases and the efficacy of this technique.
Highlights
Stability and efficiency of a CMOS sensor as detector of low energy β and γ particles
Being crucial characteristics in a surgical environment, in particular its stability against time, operating temperature, integration time and gain has been studied on laboratory measurements
This study suggests that a dedicated CMOS Image Sensor represents the ideal candidate detector for Radio Guided Surgery (RGS), able to massively increase the amount of application cases and the efficacy of this technique
Summary
Stability and efficiency of a CMOS sensor as detector of low energy β and γ particles. : Radio Guided Surgery (RGS) is a nuclear medicine technique allowing the surgeon to identify tumor residuals in real time with a millimetric resolution, thanks to a radiopharmaceutical as tracer and a probe as detector. The use of β− emitters, instead of γ or β+, has been recently proposed with the aim to increase the technique sensitivity and reducing both the administered activity to the patient and the medical exposure. The possibility to use the commercial CMOS Image Sensor MT9V115, originally designed for visible light imaging, as β− radiation detector RGS is discussed. Its validation against experimental data allowed us to obtain efficiency curves for both β and γ particles, and to evaluate the effect of the covering heavy resin protective layer that is present in the “off the shelf”
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
